Construction and immunogenicity of DNA vaccine of Ag85A gene of mycobacterium tuberculosis

陈海文,王子明,范雄林,石涛,秦兆寅,贺大林,李元,徐志凯

DOI: https://doi.org/10.3969/j.issn.1671-8259.2003.05.003

2003-01-01

Abstract:Objective: To construct DNA vaccine based on Ag85A gene of mycobacterium tuberculosis. Methods: The gene encoding Ag85A mature protein was amplified by polymerase chain reaction (PCR) from genome of mycobacterium tuberculosis H37Rv strain, and was inserted into cloning vector pGEM-T Easy after restriction endonuclease digestion. Gene fragment encoding Ag85A mature protein was correctly inserted into the vector, which was confirmed by partial nucleotide sequencing and restriction endonuclease digestion, and then was subcloned to the same sites of eukaryotic expressing vector pcDNA3. 1. When the mice were vaccinated with recombinant eukaryotic expressing vector 4 weeks later, titers of serum antibody against Ag85A were detected by ELISA. Results: The nucleotide sequencing of the gene encoding Ag85A mature form of mycobacterium tuberculosis H37Rv strain was identical and there were no undesired mutations, the cloning gene was correctly inserted into the vector pcDNA3. 1 as confirmed by restriction endonuclease digestion of BamHI and EcoRI. Mean geometric antibody titer of Ag85A was 1:1 000 by ELISA. Conclusion: DNA vaccine constructed and expressed successfully based on the gene encoding Ag85A mature protein of mycobacterium tuberculosis lays a foundation for further research into the prevention and treatment of tuberculosis and carcinoma.